Selected research
Industry Research
Non-invasive Prenatal Paternity Testing(NIPPT) Industry Research Report 2026
Market perspective
The global Non-invasive Prenatal Paternity Testing(NIPPT) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Non-invasive Prenatal Paternity Testing(NIPPT) market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Non-invasive Prenatal Paternity Testing(NIPPT) market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Non-invasive Prenatal Paternity Testing(NIPPT) market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Non-invasive Prenatal Paternity Testing(NIPPT) include BGI Genomics, Ultrasound Plus, Roche company, PrenatalGeneticslab, Natera, LabCorp, International Biosciences, Illumina and Express Diagnostic Center (EDC), among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Non-invasive Prenatal Paternity Testing(NIPPT) market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Non-invasive Prenatal Paternity Testing(NIPPT).
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Non-invasive Prenatal Paternity Testing(NIPPT) Market by Company
BGI Genomics
Ultrasound Plus
Roche company
PrenatalGeneticslab
Natera
LabCorp
International Biosciences
Illumina
Express Diagnostic Center (EDC)
EasyDNA
DDC
Axis DNA Labs
AlphaBiolabs
AffinityDNA
Acecgt Group
Non-invasive Prenatal Paternity Testing(NIPPT) Segment by Type
Reagents
Service
Non-invasive Prenatal Paternity Testing(NIPPT) Segment by Application
Non-legal Paternity Test
Legal Paternity Test
Non-invasive Prenatal Paternity Testing(NIPPT) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-invasive Prenatal Paternity Testing(NIPPT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Non-invasive Prenatal Paternity Testing(NIPPT) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-invasive Prenatal Paternity Testing(NIPPT).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Non-invasive Prenatal Paternity Testing(NIPPT) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Reagents
- Service
Applications
- Non-legal Paternity Test
- Legal Paternity Test
Companies covered
- BGI Genomics
- Ultrasound Plus
- Roche company
- PrenatalGeneticslab
- Natera
- LabCorp
- International Biosciences
- Illumina
- Express Diagnostic Center (EDC)
- EasyDNA
- DDC
- Axis DNA Labs
- AlphaBiolabs
- AffinityDNA
- Acecgt Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Non-invasive Prenatal Paternity Testing(NIPPT) by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Reagents
- 2.2.3 Service
- 2.3 Non-invasive Prenatal Paternity Testing(NIPPT) by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Non-legal Paternity Test
- 2.3.3 Legal Paternity Test
- 2.4 Assumptions and Limitations
3 Non-invasive Prenatal Paternity Testing(NIPPT) Breakdown Data by Type
- 3.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Historic Market Size by Type (2021-2026)
- 3.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Forecasted Market Size by Type (2027-2032)
4 Non-invasive Prenatal Paternity Testing(NIPPT) Breakdown Data by Application
- 4.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Historic Market Size by Application (2021-2026)
- 4.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Perspective (2021-2032)
- 5.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Growth Trends by Region
- 5.2.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Non-invasive Prenatal Paternity Testing(NIPPT) Historic Market Size by Region (2021-2026)
- 5.2.3 Non-invasive Prenatal Paternity Testing(NIPPT) Forecasted Market Size by Region (2027-2032)
- 5.3 Non-invasive Prenatal Paternity Testing(NIPPT) Market Dynamics
- 5.3.1 Non-invasive Prenatal Paternity Testing(NIPPT) Industry Trends
- 5.3.2 Non-invasive Prenatal Paternity Testing(NIPPT) Market Drivers
- 5.3.3 Non-invasive Prenatal Paternity Testing(NIPPT) Market Challenges
- 5.3.4 Non-invasive Prenatal Paternity Testing(NIPPT) Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Non-invasive Prenatal Paternity Testing(NIPPT) Players by Revenue
- 6.1.1 Global Top Non-invasive Prenatal Paternity Testing(NIPPT) Players by Revenue (2021-2026)
- 6.1.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Market Share by Players (2021-2026)
- 6.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Non-invasive Prenatal Paternity Testing(NIPPT) Head Office and Area Served
- 6.4 Global Non-invasive Prenatal Paternity Testing(NIPPT) Players, Product Type & Application
- 6.5 Global Non-invasive Prenatal Paternity Testing(NIPPT) Manufacturers Established Date
- 6.6 Global Non-invasive Prenatal Paternity Testing(NIPPT) Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Non-invasive Prenatal Paternity Testing(NIPPT) Market Size (2021-2032)
- 7.2 North America Non-invasive Prenatal Paternity Testing(NIPPT) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Country (2021-2026)
- 7.4 North America Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Non-invasive Prenatal Paternity Testing(NIPPT) Market Size (2021-2032)
- 8.2 Europe Non-invasive Prenatal Paternity Testing(NIPPT) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Country (2021-2026)
- 8.4 Europe Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Non-invasive Prenatal Paternity Testing(NIPPT) Market Size (2021-2032)
- 9.2 Asia-Pacific Non-invasive Prenatal Paternity Testing(NIPPT) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Non-invasive Prenatal Paternity Testing(NIPPT) Market Size (2021-2032)
- 10.2 South America Non-invasive Prenatal Paternity Testing(NIPPT) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Country (2021-2026)
- 10.4 South America Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Non-invasive Prenatal Paternity Testing(NIPPT) Market Size (2021-2032)
- 11.2 Middle East & Africa Non-invasive Prenatal Paternity Testing(NIPPT) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 BGI Genomics
- 12.1.1 BGI Genomics Company Information
- 12.1.2 BGI Genomics Business Overview
- 12.1.3 BGI Genomics Revenue in Non-invasive Prenatal Paternity Testing(NIPPT) Business (2021-2026)
- 12.1.4 BGI Genomics Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
- 12.1.5 BGI Genomics Recent Developments
- 12.2 Ultrasound Plus
- 12.2.1 Ultrasound Plus Company Information
- 12.2.2 Ultrasound Plus Business Overview
- 12.2.3 Ultrasound Plus Revenue in Non-invasive Prenatal Paternity Testing(NIPPT) Business (2021-2026)
- 12.2.4 Ultrasound Plus Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
- 12.2.5 Ultrasound Plus Recent Developments
- 12.3 Roche company
- 12.3.1 Roche company Company Information
- 12.3.2 Roche company Business Overview
- 12.3.3 Roche company Revenue in Non-invasive Prenatal Paternity Testing(NIPPT) Business (2021-2026)
- 12.3.4 Roche company Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
- 12.3.5 Roche company Recent Developments
- 12.4 PrenatalGeneticslab
- 12.4.1 PrenatalGeneticslab Company Information
- 12.4.2 PrenatalGeneticslab Business Overview
- 12.4.3 PrenatalGeneticslab Revenue in Non-invasive Prenatal Paternity Testing(NIPPT) Business (2021-2026)
- 12.4.4 PrenatalGeneticslab Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
- 12.4.5 PrenatalGeneticslab Recent Developments
- 12.5 Natera
- 12.5.1 Natera Company Information
- 12.5.2 Natera Business Overview
- 12.5.3 Natera Revenue in Non-invasive Prenatal Paternity Testing(NIPPT) Business (2021-2026)
- 12.5.4 Natera Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
- 12.5.5 Natera Recent Developments
- 12.6 LabCorp
- 12.6.1 LabCorp Company Information
- 12.6.2 LabCorp Business Overview
- 12.6.3 LabCorp Revenue in Non-invasive Prenatal Paternity Testing(NIPPT) Business (2021-2026)
- 12.6.4 LabCorp Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
- 12.6.5 LabCorp Recent Developments
- 12.7 International Biosciences
- 12.7.1 International Biosciences Company Information
- 12.7.2 International Biosciences Business Overview
- 12.7.3 International Biosciences Revenue in Non-invasive Prenatal Paternity Testing(NIPPT) Business (2021-2026)
- 12.7.4 International Biosciences Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
- 12.7.5 International Biosciences Recent Developments
- 12.8 Illumina
- 12.8.1 Illumina Company Information
- 12.8.2 Illumina Business Overview
- 12.8.3 Illumina Revenue in Non-invasive Prenatal Paternity Testing(NIPPT) Business (2021-2026)
- 12.8.4 Illumina Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
- 12.8.5 Illumina Recent Developments
- 12.9 Express Diagnostic Center (EDC)
- 12.9.1 Express Diagnostic Center (EDC) Company Information
- 12.9.2 Express Diagnostic Center (EDC) Business Overview
- 12.9.3 Express Diagnostic Center (EDC) Revenue in Non-invasive Prenatal Paternity Testing(NIPPT) Business (2021-2026)
- 12.9.4 Express Diagnostic Center (EDC) Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
- 12.9.5 Express Diagnostic Center (EDC) Recent Developments
- 12.10 EasyDNA
- 12.10.1 EasyDNA Company Information
- 12.10.2 EasyDNA Business Overview
- 12.10.3 EasyDNA Revenue in Non-invasive Prenatal Paternity Testing(NIPPT) Business (2021-2026)
- 12.10.4 EasyDNA Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
- 12.10.5 EasyDNA Recent Developments
- 12.11 DDC
- 12.11.1 DDC Company Information
- 12.11.2 DDC Business Overview
- 12.11.3 DDC Revenue in Non-invasive Prenatal Paternity Testing(NIPPT) Business (2021-2026)
- 12.11.4 DDC Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
- 12.11.5 DDC Recent Developments
- 12.12 Axis DNA Labs
- 12.12.1 Axis DNA Labs Company Information
- 12.12.2 Axis DNA Labs Business Overview
- 12.12.3 Axis DNA Labs Revenue in Non-invasive Prenatal Paternity Testing(NIPPT) Business (2021-2026)
- 12.12.4 Axis DNA Labs Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
- 12.12.5 Axis DNA Labs Recent Developments
- 12.13 AlphaBiolabs
- 12.13.1 AlphaBiolabs Company Information
- 12.13.2 AlphaBiolabs Business Overview
- 12.13.3 AlphaBiolabs Revenue in Non-invasive Prenatal Paternity Testing(NIPPT) Business (2021-2026)
- 12.13.4 AlphaBiolabs Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
- 12.13.5 AlphaBiolabs Recent Developments
- 12.14 AffinityDNA
- 12.14.1 AffinityDNA Company Information
- 12.14.2 AffinityDNA Business Overview
- 12.14.3 AffinityDNA Revenue in Non-invasive Prenatal Paternity Testing(NIPPT) Business (2021-2026)
- 12.14.4 AffinityDNA Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
- 12.14.5 AffinityDNA Recent Developments
- 12.15 Acecgt Group
- 12.15.1 Acecgt Group Company Information
- 12.15.2 Acecgt Group Business Overview
- 12.15.3 Acecgt Group Revenue in Non-invasive Prenatal Paternity Testing(NIPPT) Business (2021-2026)
- 12.15.4 Acecgt Group Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
- 12.15.5 Acecgt Group Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst